INVESTING & PARTNERING

The Exogenix laboratory is always interesting in finding new collaborations that drive research forwards.

If you are interested in investing in or partnering with us to develop this technology for your needs, please contact us here.

 

Benefit: Protected intellectual property providing commercial competitive advantage. A drug delivery vehicle that can be used to deliver gene editing or silencing drugs that can target virtually any disease. A technology that can be applied to a wide range of disorders, branching out into several market niches which are typically very specialised. A personalised drug that can be tailored to patients' specific needs. 

 

Opportunity: The University of Greenwich wholy ownes this IP and is seeking partners for the development and commercialisation of these technologies in the major territories.

 

IP Status: Patent protection exists for both the exosome loading Exogenix technology in the form of patent application (WO/2020/030923) and (WO2014203008) for our Anthragenix technology.

 

Contact Us 

Tel +44 (0) 20 833 318 207

Email science@exogenix.co.uk 

The Exogenix Laboratory 

University of Greenwich 

Central Avenue, 

Chatham Maritime

Kent, U.K. 

© Exogenix Laboratory 2020